BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17298482)

  • 1. Carisoprodol use and abuse in Norway: a pharmacoepidemiological study.
    Bramness JG; Furu K; Engeland A; Skurtveit S
    Br J Clin Pharmacol; 2007 Aug; 64(2):210-8. PubMed ID: 17298482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlapping prescriptions of opioids, benzodiazepines, and carisoprodol: "Holy Trinity" prescribing in the state of Florida.
    Wang Y; Delcher C; Li Y; Goldberger BA; Reisfield GM
    Drug Alcohol Depend; 2019 Dec; 205():107693. PubMed ID: 31751873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prescription shopping of addictive drugs in Norway].
    Winther RB; Bramness JG
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):517-20. PubMed ID: 19282887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database.
    Fredheim OM; Skurtveit S; Moroz A; Breivik H; Borchgrevink PC
    Acta Anaesthesiol Scand; 2009 May; 53(5):627-33. PubMed ID: 19419357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?
    Skurtveit S; Furu K; Kaasa S; Borchgrevink PC
    Eur J Pain; 2009 Oct; 13(9):949-53. PubMed ID: 19095476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carisoprodol (soma): abuse potential and physician unawareness.
    Reeves RR; Carter OS; Pinkofsky HB; Struve FA; Bennett DM
    J Addict Dis; 1999; 18(2):51-6. PubMed ID: 10334375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment due to intake of carisoprodol.
    Bramness JG; Skurtveit S; Mørland J
    Drug Alcohol Depend; 2004 Jun; 74(3):311-8. PubMed ID: 15194209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Centrally acting muscle relaxants and traffic hazards].
    Bramness JG; Skurtveit S; Grung M; Mørland J
    Tidsskr Nor Laegeforen; 2000 Jun; 120(17):1966-9. PubMed ID: 11008526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of traffic accidents after prescriptions of carisoprodol.
    Bramness JG; Skurtveit S; Mørland J; Engeland A
    Accid Anal Prev; 2007 Sep; 39(5):1050-5. PubMed ID: 17854578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carisoprodol: a drug of continuing abuse.
    Reeves RR; Pinkofsky HB; Carter OS
    J Am Osteopath Assoc; 1997 Dec; 97(12):723-4. PubMed ID: 9439144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carisoprodol--one more time].
    Reiestad F; Fagerlund B
    Tidsskr Nor Laegeforen; 2002 Jan; 122(3):327. PubMed ID: 11894608
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the frequency of carisoprodol withdrawal syndrome increasing?
    Reeves RR; Hammer JS; Pendarvis RO
    Pharmacotherapy; 2007 Oct; 27(10):1462-6. PubMed ID: 17896902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential.
    Bramness JG; Furu K; Skurtveit S; Engeland A
    Clin Pharmacol Ther; 2012 Mar; 91(3):438-41. PubMed ID: 22318620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carisoprodol: abuse potential and withdrawal syndrome.
    Reeves RR; Burke RS
    Curr Drug Abuse Rev; 2010 Mar; 3(1):33-8. PubMed ID: 20088817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carisoprodol legal status and patterns of abuse.
    Fass JA
    Ann Pharmacother; 2010 Dec; 44(12):1962-7. PubMed ID: 21062909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of carisoprodol (Somadril)].
    Rygnestad T; Aamo T
    Tidsskr Nor Laegeforen; 1997 Mar; 117(7):1004-5. PubMed ID: 9102996
    [No Abstract]   [Full Text] [Related]  

  • 18. The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study.
    Gjerden P; Bramness JG; Slørdal L
    Br J Clin Pharmacol; 2009 Feb; 67(2):228-33. PubMed ID: 19094158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carisoprodol abuse in Mississippi.
    Reeves RR; Henderson RH; Ladner ME
    J Miss State Med Assoc; 2007 Dec; 48(12):363-5. PubMed ID: 19292137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.